RFICs
PRODUCTS
-
The Challenge: Building Scalable Viral Vector Programs
Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.
-
Aria FAST mobile water units deliver the water you need, when and where you need it. Our mobile systems are easily installed and produce highquality water in as little as four hours after utility connections are complete.
-
If you need robust and reliable fill-finish equipment that causes minimal disruption to your existing footprint, the Hull i-Dositecno LI Versa-Line™ Pharmaceutical Filling equipment is here to help! Accessibility from one side means you can install at the wall for a linear filling and capping system that fits neatly into any space.
-
On-site labs with our own personnel offer greater control of samples and timelines, minimizing risk for our customers.
-
The LabAlert™ wireless laboratory monitoring system is designed to provide secure, real-time oversight of critical lab equipment and environments. This cloud-based platform enables centralized monitoring of temperature, humidity, and CO₂ levels across single or multiple facilities, with customizable alerts delivered via web or mobile app. The system supports FDA 21 CFR Part 11 compliance and eliminates manual data logging with secure, centralized recordkeeping. Easy to install and scalable, LabAlert also includes tools for preventative maintenance tracking and cost management.
WHITE PAPERS AND CASE STUDIES
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Improved Fluorescence Detection Performance
Discover how Semrock Avant™ optical filters enhance fluorescence imaging of small Stokes Shift probes by providing steeper edges, reduced variation, and stronger blocking.
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
-
Repairing A Suspended Pipe Within 30 Minutes With HYMAX Permanent Repair Sleeve
In the picturesque village of Arzacq-Arraziguet in southwestern France, a critical water pipeline repair showcased the efficiency of modern tools and techniques.
-
Disinfection Of Acid Wastewater Discharge In Taiwan
A leading semiconductor foundry in Taiwan, internationally renowned for its advanced manufacturing technology and continuous innovation, needed to treat Acid Wastewater Discharge (AWD) in its backend discharge system.
-
What Changes When Your CPV Goes Digital
Explore the advantages of digitalizing Continued Process Verification (CPV) through the experience of a pharmaceutical company step-by-step.
-
Tailored ISO 5 RABs Unit To Protect AST's Patented Filling Machine
Uncover how AST's satisfaction with Germfree's solution led to the acquisition of two additional units, showcasing the project's success and Germfree's expertise in tailored cleanroom solutions.
-
ProPharma Supports A Contract Manufacturer's Form 483 Response
Learn how a small contract manufacturer navigated a complex FDA 483 Observation notice and implemented effective remediation strategies that addressed multiple system-wide concerns.
-
Elevating Purity: Racemizing Pharmaceutical Products In Flow Microreactors
Discover how our process development team resolved a racemization challenge by delivering a biologically active racemic mixture while maintaining compound purity.
-
Optimizing Kitting For Cell Therapy Trials In Pediatric Oncology
Precision for Medicine’s Kitting team played a crucial role in overcoming this challenges of a Phase I multicenter pediatric cell therapy trial targeting relapsed or refractory solid tumors.
-
Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan
A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. See how they accomplished it and more with this case study.
-
City Of Lodi Employs GAC To Remove Contaminants From Groundwater
In this case study, read about AV's unique Concept to Commission approach which enabled a team to design, manufacture, and install GAC systems and interconnecting site pipe in just 10 working hours.
NEWS
-
PulpFixin Announces Strategic Distribution Partnership With Wildcat Laboratory Solutions To Expand Sustainable Lab Products Across The UK And EU4/14/2025
PulpFixin, an innovator of sustainable laboratory products, announced today a new distribution partnership with Wildcat Laboratory Solutions a leading provider of lab equipment and solutions across the United Kingdom and European Union.
-
Consulta Remedios Selects Kevel's Retail Media Cloud To Power Its Next-Generation Advertising Platform5/2/2025
Kevel, the leading provider of API-based retail media ad serving technology, today announced that Consulta Remédios, Brazil's largest medicine price comparison platform, has selected Kevel's Retail Media Cloud to power the development and enhancement of its in-house retail media network.
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
Dielectric Partners With Foccus Digital For Brazilian Broadcast Growth8/15/2025
Dielectric’s Brazilian presence is about to radiate stronger through a new partnership with Foccus Digital that expand Dielectric’s broadcast business throughout the country.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
ABOUT
About Nutrient Removal
Nutrient removal from wastewater consists of treating wastewater to remove nitrogen and phosphorus before it reenters natural waterways. High levels of nitrogen and phosphorus in wastewater cause eutrophication, a process where excess nutrients stimulate excessive plant growth such as algal blooms and cyanobacteria. The decomposition of the algae by bacteria uses up the oxygen in the water causing other organisms to die. This creates more organic matter for the bacteria to decompose. In addition, some algal blooms can produce toxins that contaminate drinking water supplies.
As authorized by the Clean Water Act, the National Pollutant Discharge Elimination System (NPDES) permit program regulates point sources, such as municipal wastewater treatment plants, that discharge pollutants as effluent into the waters of the United States. In recent years, many of the States’ environmental bodies have lowered nutrient limits to arrest eutrophication. Maryland’s effort to protect the Chesapeake Bay and its tidal tributaries is perhaps the most notable example of nutrient removal in the US. Nutrient removal continues to be a growing area of focus for wastewater treatment throughout the world.
The removal of nitrogen and phosphorus require different nutrient removal processes. To remove nitrogen, the nitrogen is oxidized from ammonia to become nitrate through a process called nitrification. This process is then followed by denitrification where the nitrate is reduced to nitrogen gas which is released to the atmosphere and removed from the wastewater.
Nitrification is a two-step aerobic process which typically takes place in aeration tanks. Denitrification requires anoxic conditions to encourage the appropriate biological conditions to form. The activated sludge process is often used to reduce nitrate to nitrogen gas in anoxic or denitrification tanks.
Phosphorus can be removed biologically using polyphosphate accumulating organisms (PAOs) which accumulate large quantities of phosphorus within their cells and separate it from treated water. Phosphorus removal can also be achieved by chemical removal. Once removed as sludge, phosphorus may be stored in a land fill. However, many municipalities and treatment facilities are looking to resell the biosolids for use in fertilizer.